Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Telephone-Based Shared Decision-making for Lung Cancer Screening in Primary Care.

Fagan HB, Fournakis NA, Jurkovitz C, Petrich AM, Zhang Z, Katurakes N, Myers RE.

J Cancer Educ. 2019 May 9. doi: 10.1007/s13187-019-01528-z. [Epub ahead of print]

PMID:
31069714
2.

Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial.

Zelenetz AD, Salles G, Mason KD, Casulo C, Le Gouill S, Sehn LH, Tilly H, Cartron G, Chamuleau MED, Goy A, Tam CS, Lugtenburg PJ, Petrich AM, Sinha A, Samineni D, Herter S, Ingalla E, Szafer-Glusman E, Klein C, Sampath D, Kornacker M, Mobasher M, Morschhauser F.

Blood. 2019 May 2;133(18):1964-1976. doi: 10.1182/blood-2018-11-880526. Epub 2019 Mar 8.

3.

Diagnostic Interpretation Guidance for Pediatric Enteric Pathogens: A Modified Delphi Consensus Process.

Stang AS, Trudeau M, Vanderkooi OG, Lee BE, Chui L, Pang XL, Allen V, Burnham CD, Goldfarb DM, MacDonald J, Parsons B, Petrich A, Pollari F, Tarr PI, Tipples G, Zhuo R, Freedman SB.

Can J Infect Dis Med Microbiol. 2018 Sep 27;2018:2589826. doi: 10.1155/2018/2589826. eCollection 2018.

4.

Decision Support and Navigation to Increase Colorectal Cancer Screening Among Hispanic Patients.

Myers RE, Stello B, Daskalakis C, Sifri R, González ET, DiCarlo M, Johnson MB, Hegarty SE, Shaak K, Rivera A, Gordils-Molina L, Petrich A, Careyva B, de-Ortiz R, Diaz L.

Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):384-391. doi: 10.1158/1055-9965.EPI-18-0260. Epub 2018 Oct 17.

PMID:
30333221
5.

Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study.

de Vos S, Swinnen LJ, Wang D, Reid E, Fowler N, Cordero J, Dunbar M, Enschede SH, Nolan C, Petrich AM, Ross JA, Salem AH, Verdugo M, Agarwal S, Zhou L, Kozloff M, Nastoupil LJ, Flowers CR.

Ann Oncol. 2018 Sep 1;29(9):1932-1938. doi: 10.1093/annonc/mdy256.

6.

Childhood exposures to discarded needles and other objects potentially contaminated with blood-borne pathogens in Toronto, Canada.

Kordy F, Petrich A, Read SE, Bitnun A.

Paediatr Child Health. 2017 Oct;22(7):372-376. doi: 10.1093/pch/pxx110. Epub 2017 Sep 25.

7.

Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose-adjusted EPOCH plus rituximab.

Malecek MK, Petrich AM, Rozell S, Chu B, Trifilio S, Galanina N, Maurer M, Farooq U, Link BK, Nowakowski GS, Nabhan C, Ayed AO.

Am J Hematol. 2017 Nov;92(11):1156-1162. doi: 10.1002/ajh.24864. Epub 2017 Aug 17.

8.

Measuring influenza RNA quantity after prolonged storage or multiple freeze/thaw cycles.

Granados A, Petrich A, McGeer A, Gubbay JB.

J Virol Methods. 2017 Sep;247:45-50. doi: 10.1016/j.jviromet.2017.05.018. Epub 2017 May 29.

PMID:
28572040
9.

Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.

Landsburg DJ, Falkiewicz MK, Maly J, Blum KA, Howlett C, Feldman T, Mato AR, Hill BT, Li S, Medeiros LJ, Torka P, Hernandez-Ilizaliturri F, Reddy NM, Singavi A, Fenske TS, Chavez JC, Kaplan JB, Behdad A, Petrich AM, Bast MA, Vose JM, Olszewski AJ, Costa C, Lansigan F, Gerson JN, Barta SK, Calzada O, Cohen JB, Lue JK, Amengual JE, Rivera X, Persky DO, Peace DJ, Nathan S, Cassaday RD.

J Clin Oncol. 2017 Jul 10;35(20):2260-2267. doi: 10.1200/JCO.2017.72.2157. Epub 2017 May 5.

10.

University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL.

Galanina N, Smith SM, Liao C, Petrich A, Libao B, Gartenhaus R, Westin JR, Cohen KS, Knost JA, Stadler WM, Doyle A, Karrison T, Gordon LI, Evens AM.

Br J Haematol. 2018 Apr;181(2):264-267. doi: 10.1111/bjh.14544. Epub 2017 Apr 17. No abstract available.

11.

Ibrutinib, a Bruton's tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivity.

Regan JA, Cao Y, Dispenza MC, Ma S, Gordon LI, Petrich AM, Bochner BS.

J Allergy Clin Immunol. 2017 Sep;140(3):875-879.e1. doi: 10.1016/j.jaci.2017.03.013. Epub 2017 Apr 4. No abstract available.

PMID:
28389390
12.

Mycobacterium Fortuitum Bloodstream Infection in a Very Low Birth Weight Preterm Neonate.

Hodgson K, Isabel S, McNamara P, Petrich A, Bitnun A.

Pediatr Infect Dis J. 2017 Aug;36(8):800-802. doi: 10.1097/INF.0000000000001592.

PMID:
28333709
13.

Distribution and phylogeny of Brachyspira spp. in human intestinal spirochetosis revealed by FISH and 16S rRNA-gene analysis.

Rojas P, Petrich A, Schulze J, Wiessner A, Loddenkemper C, Epple HJ, Sterlacci W, Vieth M, Kikhney J, Moter A.

Anaerobe. 2017 Oct;47:25-32. doi: 10.1016/j.anaerobe.2017.03.012. Epub 2017 Mar 12.

PMID:
28300642
14.

Impact of treatment variability on survival in immuno-competent and immuno-compromised patients with primary central nervous lymphoma.

Karmali R, Nabhan C, Petrich AM, Raizer J, Peace D, Lukas R, Gordon LI, Basu S, Chukkapalli V, Venugopal P.

Br J Haematol. 2017 Apr;177(1):72-79. doi: 10.1111/bjh.14522. Epub 2017 Feb 17.

PMID:
28211579
15.

Is Ureaplasma spp. the leading causative agent of acute chorioamnionitis in women with preterm birth?

Kikhney J, von Schöning D, Steding I, Schulze J, Petrich A, Hiergeist A, Reischl U, Moter A, Thomas A.

Clin Microbiol Infect. 2017 Feb;23(2):119.e1-119.e7. doi: 10.1016/j.cmi.2016.10.010. Epub 2016 Oct 15.

16.

Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.

Landsburg DJ, Falkiewicz MK, Petrich AM, Chu BA, Behdad A, Li S, Medeiros LJ, Cassaday RD, Reddy NM, Bast MA, Vose JM, Kruczek KR, Smith SE, Patel P, Hernandez-Ilizaliturri F, Karmali R, Rajguru S, Yang DT, Maly JJ, Blum KA, Zhao W, Vanslambrouck C, Nabhan C.

Br J Haematol. 2016 Nov;175(4):631-640. doi: 10.1111/bjh.14282. Epub 2016 Jul 29.

17.

Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study.

Myers RE, Leader AE, Censits JH, Trabulsi EJ, Keith SW, Petrich AM, Quinn AM, Den RB, Hurwitz MD, Lallas CD, Hegarty SE, Dicker AP, Zeigler-Johnson CM, Giri VN, Ayaz H, Gomella LG.

J Cancer Educ. 2018 Feb;33(1):180-185. doi: 10.1007/s13187-016-1073-7.

PMID:
27418065
18.

Are We There Yet? Impact of the First International Standard for Cytomegalovirus DNA on the Harmonization of Results Reported on Plasma Samples.

Preiksaitis JK, Hayden RT, Tong Y, Pang XL, Fryer JF, Heath AB, Cook L, Petrich AK, Yu B, Caliendo AM.

Clin Infect Dis. 2016 Sep 1;63(5):583-9. doi: 10.1093/cid/ciw370. Epub 2016 Jun 15.

PMID:
27307504
19.

Use of class I histone deacetylase inhibitor romidepsin in combination regimens.

Petrich A, Nabhan C.

Leuk Lymphoma. 2016 Aug;57(8):1755-65. doi: 10.3109/10428194.2016.1160082. Epub 2016 Apr 27. Review.

20.

Durable Responses With Maintenance Dose-Sparing Regimens of Romidepsin in Cutaneous T-Cell Lymphoma.

Martinez-Escala ME, Kuzel TM, Kaplan JB, Petrich A, Nardone B, Rosen ST, Guitart J.

JAMA Oncol. 2016 Jun 1;2(6):790-3. doi: 10.1001/jamaoncol.2016.0004.

PMID:
27054291
21.

The evolving role of lenalidomide in non-Hodgkin lymphoma.

Galanina N, Petrich A, Nabhan C.

Leuk Lymphoma. 2016 Jul;57(7):1507-16. doi: 10.3109/10428194.2016.1146949. Epub 2016 Feb 22. Review.

PMID:
26902680
22.

Crib Mattress Investigation: A quality improvement study to assess mattress cover permeability and bacterial growth in crib mattresses.

Yu M, Cross K, Petrich A, Fish J.

Am J Infect Control. 2016 Jul 1;44(7):837-9. doi: 10.1016/j.ajic.2015.12.014. Epub 2016 Feb 5.

PMID:
26856469
23.

Spherical fused silica cells filled with pure helium for nuclear magnetic resonance-magnetometry.

Maul A, Blümler P, Heil W, Nikiel A, Otten E, Petrich A, Schmidt T.

Rev Sci Instrum. 2016 Jan;87(1):015103. doi: 10.1063/1.4938251.

PMID:
26827349
24.

Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.

Landsburg DJ, Petrich AM, Abramson JS, Sohani AR, Press O, Cassaday R, Chavez JC, Song K, Zelenetz AD, Gandhi M, Shah N, Fenske TS, Jaso J, Medeiros LJ, Yang DT, Nabhan C.

Cancer. 2016 Feb 15;122(4):559-64. doi: 10.1002/cncr.29781. Epub 2015 Nov 13.

25.

Fluorescence in situ hybridization for the identification of Treponema pallidum in tissue sections.

Petrich A, Rojas P, Schulze J, Loddenkemper C, Giacani L, Schneider T, Hertel M, Kikhney J, Moter A.

Int J Med Microbiol. 2015 Oct;305(7):709-18. doi: 10.1016/j.ijmm.2015.08.022. Epub 2015 Aug 28.

PMID:
26365167
26.

Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.

Evens AM, Kanakry JA, Sehn LH, Kritharis A, Feldman T, Kroll A, Gascoyne RD, Abramson JS, Petrich AM, Hernandez-Ilizaliturri FJ, Al-Mansour Z, Adeimy C, Hemminger J, Bartlett NL, Mato A, Caimi PF, Advani RH, Klein AK, Nabhan C, Smith SM, Fabregas JC, Lossos IS, Press OW, Fenske TS, Friedberg JW, Vose JM, Blum KA.

Am J Hematol. 2015 Sep;90(9):778-83. doi: 10.1002/ajh.24082.

27.

Detection of enterovirus D68 in Canadian laboratories.

Hatchette TF, Drews SJ, Grudeski E, Booth T, Martineau C, Dust K, Garceau R, Gubbay J, Karnauchow T, Krajden M, Levett PN, Mazzulli T, McDonald RR, McNabb A, Mubareka S, Needle R, Petrich A, Richardson S, Rutherford C, Smieja M, Tellier R, Tipples G, LeBlanc JJ.

J Clin Microbiol. 2015 May;53(5):1748-51. doi: 10.1128/JCM.03686-14. Epub 2015 Mar 4.

28.

Is virus coinfection a predictor of severity in children with viral respiratory infections?

Asner SA, Rose W, Petrich A, Richardson S, Tran DJ.

Clin Microbiol Infect. 2015 Mar;21(3):264.e1-6. doi: 10.1016/j.cmi.2014.08.024. Epub 2014 Oct 29.

29.

Aches and pains with a shocking rash.

Chacko A, Mahant S, Petrich A, Wadhwa A.

Can J Infect Dis Med Microbiol. 2014 Nov-Dec;25(6):323-5. No abstract available.

30.

Factors predicting survival in peripheral T-cell lymphoma in the USA: a population-based analysis of 8802 patients in the modern era.

Petrich AM, Helenowski IB, Bryan LJ, Rozell SA, Galamaga R, Nabhan C.

Br J Haematol. 2015 Mar;168(5):708-18. doi: 10.1111/bjh.13202. Epub 2014 Nov 7.

PMID:
25382108
31.

Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.

Petrich AM, Gandhi M, Jovanovic B, Castillo JJ, Rajguru S, Yang DT, Shah KA, Whyman JD, Lansigan F, Hernandez-Ilizaliturri FJ, Lee LX, Barta SK, Melinamani S, Karmali R, Adeimy C, Smith S, Dalal N, Nabhan C, Peace D, Vose J, Evens AM, Shah N, Fenske TS, Zelenetz AD, Landsburg DJ, Howlett C, Mato A, Jaglal M, Chavez JC, Tsai JP, Reddy N, Li S, Handler C, Flowers CR, Cohen JB, Blum KA, Song K, Sun HL, Press O, Cassaday R, Jaso J, Medeiros LJ, Sohani AR, Abramson JS.

Blood. 2014 Oct 9;124(15):2354-61. doi: 10.1182/blood-2014-05-578963. Epub 2014 Aug 26.

32.

MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches.

Petrich AM, Nabhan C, Smith SM.

Cancer. 2014 Dec 15;120(24):3884-95. doi: 10.1002/cncr.28899. Epub 2014 Jul 24. Review.

33.

Clinical severity of rhinovirus/enterovirus compared to other respiratory viruses in children.

Asner SA, Petrich A, Hamid JS, Mertz D, Richardson SE, Smieja M.

Influenza Other Respir Viruses. 2014 Jul;8(4):436-42. doi: 10.1111/irv.12255. Epub 2014 May 7.

34.

Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event.

Gandhi MD, Evens AM, Fenske TS, Hamlin P, Coiffier B, Engert A, Moskowitz AJ, Ghosh N, Petrich AM, Lomasney J, Chadburn A, Wood GS, Salva K, Nardone B, Trifilio SM, Raisch DW, West DP, Gordon LI, Winter JN.

Blood. 2014 May 1;123(18):2895-7. doi: 10.1182/blood-2014-03-561878. No abstract available.

35.

Multiple successful desensitizations to brentuximab vedotin: a case report and literature review.

DeVita MD, Evens AM, Rosen ST, Greenberger PA, Petrich AM.

J Natl Compr Canc Netw. 2014 Apr;12(4):465-71. Review.

PMID:
24717566
36.

Phase II study of alemtuzumab-rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: short- and long-term outcomes.

Frankfurt O, Ma S, Gordon L, Winter JN, Horowitz JM, Rademaker A, Weitner BB, Peterson LC, Altman JK, Tallman MS, Petrich A, Rosen ST.

Leuk Lymphoma. 2015 Feb;56(2):315-23. doi: 10.3109/10428194.2014.910654. Epub 2014 Jun 17.

PMID:
24707943
37.

F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma.

Gentzler RD, Evens AM, Rademaker AW, Weitner BB, Mittal BB, Dillehay GL, Petrich AM, Altman JK, Frankfurt O, Variakojis D, Singhal S, Mehta J, Williams S, Kaminer L, Gordon LI, Winter JN.

Br J Haematol. 2014 Jun;165(6):793-800. doi: 10.1111/bjh.12824. Epub 2014 Mar 15.

PMID:
24628515
39.

Brentuximab vedotin in patients with relapsed HIV-related lymphoma.

Gandhi M, Petrich A.

J Natl Compr Canc Netw. 2014 Jan;12(1):16-9; quiz 19.

PMID:
24453289
40.

Fluorescence in situ hybridization for identification of microorganisms in acute chorioamnionitis.

Schmiedel D, Kikhney J, Masseck J, Rojas Mencias PD, Schulze J, Petrich A, Thomas A, Henrich W, Moter A.

Clin Microbiol Infect. 2014 Sep;20(9):O538-41. doi: 10.1111/1469-0691.12526. Epub 2014 Feb 8.

41.

Peripheral T-cell lymphoma: new therapeutic strategies.

Petrich AM, Rosen ST.

Oncology (Williston Park). 2013 Sep;27(9):878-84. Review.

42.

Validation of an rpoB gene PCR assay for detection of Tropheryma whipplei: 10 years' experience in a National Reference Laboratory.

Moter A, Schmiedel D, Petrich A, Wiessner A, Kikhney J, Schneider T, Moos V, Göbel UB, Reischl U.

J Clin Microbiol. 2013 Nov;51(11):3858-61. doi: 10.1128/JCM.01703-13. Epub 2013 Aug 21.

43.

Co-circulation of multiple genotypes of human rhinovirus during a large outbreak of respiratory illness in a veterans' long-term care home.

Mubareka S, Louie L, Wong H, Granados A, Chong S, Luinstra K, Petrich A, Smieja M, Vearncombe M, Mahony J, Simor A.

J Clin Virol. 2013 Oct;58(2):455-60. doi: 10.1016/j.jcv.2013.06.037. Epub 2013 Jul 31.

PMID:
23910934
44.

Reduced-dose carboxypeptidase-G2 successfully lowers elevated methotrexate levels in an adult with acute methotrexate-induced renal failure.

Trifilio S, Ma S, Petrich A.

Clin Adv Hematol Oncol. 2013 May;11(5):322-3. No abstract available.

PMID:
23880719
45.

Phosphorylation of threonine 333 regulates trafficking of the human sst5 somatostatin receptor.

Petrich A, Mann A, Kliewer A, Nagel F, Strigli A, Märtens JC, Pöll F, Schulz S.

Mol Endocrinol. 2013 Apr;27(4):671-82. doi: 10.1210/me.2012-1329. Epub 2013 Feb 15.

46.

Classical Hodgkin lymphoma and spontaneous regression.

Thirukonda V, Petrich A, Parekh S.

Clin Adv Hematol Oncol. 2012 Nov;10(11):765-6. Review. No abstract available.

PMID:
23271267
47.

A transplantable phosphorylation probe for direct assessment of G protein-coupled receptor activation.

Kliewer A, Mann A, Petrich A, Pöll F, Schulz S.

PLoS One. 2012;7(6):e39458. doi: 10.1371/journal.pone.0039458. Epub 2012 Jun 26.

48.

Co-localized or randomly distributed? Pair cross correlation of in vivo grown subgingival biofilm bacteria quantified by digital image analysis.

Schillinger C, Petrich A, Lux R, Riep B, Kikhney J, Friedmann A, Wolinsky LE, Göbel UB, Daims H, Moter A.

PLoS One. 2012;7(5):e37583. doi: 10.1371/journal.pone.0037583. Epub 2012 May 24.

49.

Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS Malignancy Consortium.

Bayraktar UD, Ramos JC, Petrich A, Gupta N, Lensing S, Moore PC, Reid EG, Aboulafia DM, Ratner L, Mitsuyasu R, Cooley T, Henry DH, Barr P, Noy A.

Leuk Lymphoma. 2012 Dec;53(12):2383-9. doi: 10.3109/10428194.2012.697559. Epub 2012 Jul 9.

50.

Paradigms and Controversies in the Treatment of HIV-Related Burkitt Lymphoma.

Petrich AM, Sparano JA, Parekh S.

Adv Hematol. 2012;2012:403648. doi: 10.1155/2012/403648. Epub 2012 Apr 18.

Supplemental Content

Loading ...
Support Center